Hamps Bio share price hits 5% upper circuit after listing at 90% premium

Stock market today: After receiving a robust response from the primary market investors, Hamps Bio shares listed on the BSE at a strong premium. The BSE stock listed on the BSE SME Exchange at ₹96.90 per share, delivering a robust 90 per cent listing gain to the lucky allottees. However, the SME stock didn't end here only. The newly-listed SME share further attracted buying interest by Dalal Street bulls and went on to touch an intraday high of ₹101.74 apiece. While climbing to this intraday high, the BSE SME stock touched 5 per cent upper circuit. 

The initial public offering (IPO) of Hamps Bio Limited, which opened for bidding on Friday, December 13, closed for subscription on Tuesday, December 17. According to Hamps Bio IPO subscription status, the public issue received strong investor interest, with the issue being subscribed 1,057 times at the end of the third day of bidding. 

Hamps Bio IPO issue details

1. Hamps Bio IPO date: The issue opened for subscription on Friday, December 13, and ended on Tuesday, December 17.

2. Hamps Bio IPO Price: The price band of the public issue has been fixed at ₹51 per equity share.

3. Hamps Bio IPO Size: The company aims to raise ₹6.22 crore through the IPO, which is a fresh issue of 12.22 lakh shares.

4. Hamps Bio IPO Lot Size: The IPO lot size is fixed at 2000 shares, requiring a minimum investment of ₹1,02,000 for retail investors.

5. Hamps Bio IPO reservation: The IPO offers 5.79 lakh shares to non-institutional buyers and 5.79 lakh shares to retail investors.

6. Hamps Bio IPO allotment date: The IPO allotment date is set for Wednesday, December 18. Investors who receive an allotment will see the shares in their demat accounts by Thursday, December 19, while those who do not will have their refunds processed on the same day.

7. Hamps Bio IPO listing: The SME IPO is proposed to list on the BSE SME on Friday, December 20.

8. Hamps Bio IPO GMP: According to market sources, Hamps Bio IPO GMP today is ₹46, suggesting that the stock may list at ₹97, a premium close to 100 per cent over the issue price of ₹51.

9. Hamps Bio IPO book-running lead manager and registrar: Marwadi Chandarana Intermediaries Brokers Pvt. Ltd. is the book-running lead manager of the Hamps Bio IPO, while Bigshare Services Pvt. Ltd. is the registrar for the issue. The market maker for Hamps Bio IPO is Pure Broking.

10. Hamps Bio business overview: The company is engaged in the marketing and distribution of pharmaceutical formulation products (“Pharma”) across a wide range of dosages, including tablets, syrups, capsules, injectables, oil, gel, and powder used as medicine and nutrition supplements, as well as the manufacturing of freeze-dried and frozen products (“FDFP” or “FMCG Division”) such as fruits, vegetables, herbs, and flowers.

It sells its products through more than 50 distributors’ networks as of March 31, 2024, and e-commerce platforms, including Amazon.com, Amazon.ca, Amazon.eu, Flipkart, and Jio Mart. It sells its pharma products primarily in 8 states and union territories and our FDFP products primarily in 4 countries and 22 states and union territories, as per the company's DRHP report.

Disclaimer: We advise investors to check with certified experts before taking any investment decisions.